Maxcyte Stock Price History

MXCT Stock  USD 3.52  0.14  4.14%   
If you're considering investing in MaxCyte Stock, it is important to understand the factors that can impact its price. As of today, the current price of MaxCyte stands at 3.52, as last reported on the 28th of November, with the highest price reaching 3.58 and the lowest price hitting 3.38 during the day. MaxCyte has Sharpe Ratio of -0.0793, which conveys that the firm had a -0.0793% return per unit of risk over the last 3 months. MaxCyte exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify MaxCyte's Risk Adjusted Performance of (0.05), mean deviation of 2.47, and Standard Deviation of 3.29 to check out the risk estimate we provide.
  
At this time, MaxCyte's Total Stockholder Equity is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 281.7 M in 2024, whereas Other Stockholder Equity is likely to drop slightly above 222.4 M in 2024. . At this time, MaxCyte's Price Book Value Ratio is comparatively stable compared to the past year. Price To Book Ratio is likely to gain to 2.20 in 2024, despite the fact that Price Earnings To Growth Ratio is likely to grow to (0.13). MaxCyte Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0793

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsMXCT

Estimated Market Risk

 3.33
  actual daily
29
71% of assets are more volatile

Expected Return

 -0.26
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.08
  actual daily
0
Most of other assets perform better
Based on monthly moving average MaxCyte is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of MaxCyte by adding MaxCyte to a well-diversified portfolio.
Price Book
1.7407
Enterprise Value Ebitda
(11.07)
Price Sales
8.1427
Shares Float
96.5 M
Wall Street Target Price
9.25

MaxCyte Stock Price History Chart

There are several ways to analyze MaxCyte Stock price data. The simplest method is using a basic MaxCyte candlestick price chart, which shows MaxCyte price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceSeptember 19, 20244.35
Lowest PriceNovember 18, 20243.23

MaxCyte November 28, 2024 Stock Price Synopsis

Various analyses of MaxCyte's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell MaxCyte Stock. It can be used to describe the percentage change in the price of MaxCyte from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of MaxCyte Stock.
MaxCyte Price Rate Of Daily Change 1.04 
MaxCyte Price Action Indicator 0.11 
MaxCyte Price Daily Balance Of Power 0.70 

MaxCyte November 28, 2024 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in MaxCyte Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use MaxCyte intraday prices and daily technical indicators to check the level of noise trading in MaxCyte Stock and then apply it to test your longer-term investment strategies against MaxCyte.

MaxCyte Stock Price History Data

The price series of MaxCyte for the period between Fri, Aug 30, 2024 and Thu, Nov 28, 2024 has a statistical range of 1.12 with a coefficient of variation of 6.64. The daily prices for the period are spread out with arithmetic mean of 3.78. The median price for the last 90 days is 3.79.
OpenHighLowCloseVolume
11/28/2024
 3.38  3.58  3.38  3.52 
11/27/2024 3.38  3.58  3.38  3.52  776,537 
11/26/2024 3.60  3.61  3.33  3.38  966,975 
11/25/2024 3.58  3.75  3.52  3.61  2,919,618 
11/22/2024 3.45  3.63  3.39  3.55  516,969 
11/21/2024 3.48  3.51  3.36  3.45  651,511 
11/20/2024 3.33  3.50  3.30  3.49  447,641 
11/19/2024 3.24  3.36  3.17  3.33  579,078 
11/18/2024 3.44  3.45  3.22  3.23  675,345 
11/15/2024 3.47  3.53  3.36  3.42  890,406 
11/14/2024 3.55  3.61  3.41  3.44  969,010 
11/13/2024 3.56  3.60  3.40  3.55  662,918 
11/12/2024 3.51  3.64  3.43  3.54  796,659 
11/11/2024 3.39  3.60  3.23  3.58  654,050 
11/08/2024 3.45  3.64  3.37  3.39  481,987 
11/07/2024 4.01  4.01  3.34  3.46  2,362,652 
11/06/2024 4.00  4.15  3.80  3.88  876,927 
11/05/2024 3.73  3.87  3.70  3.86  314,140 
11/04/2024 3.73  3.82  3.66  3.76  319,624 
11/01/2024 3.65  3.78  3.61  3.77  367,093 
10/31/2024 3.52  3.67  3.52  3.58  185,308 
10/30/2024 3.54  3.63  3.52  3.54  279,465 
10/29/2024 3.65  3.65  3.50  3.57  187,568 
10/28/2024 3.60  3.74  3.59  3.61  324,789 
10/25/2024 3.83  3.83  3.56  3.57  336,337 
10/24/2024 3.87  3.87  3.77  3.80  278,996 
10/23/2024 3.81  3.87  3.74  3.82  307,019 
10/22/2024 3.74  3.88  3.64  3.84  240,205 
10/21/2024 3.77  3.90  3.72  3.76  284,084 
10/18/2024 3.79  3.81  3.75  3.77  209,312 
10/17/2024 3.87  3.87  3.74  3.79  177,463 
10/16/2024 3.83  3.90  3.79  3.85  184,616 
10/15/2024 3.87  3.87  3.73  3.78  178,392 
10/14/2024 3.87  3.93  3.83  3.87  220,104 
10/11/2024 3.76  3.88  3.67  3.88  302,761 
10/10/2024 3.66  3.90  3.63  3.70  413,427 
10/09/2024 3.88  3.91  3.66  3.67  292,131 
10/08/2024 3.79  3.89  3.75  3.88  406,062 
10/07/2024 3.67  3.80  3.63  3.78  391,172 
10/04/2024 3.70  3.74  3.59  3.67  252,597 
10/03/2024 3.79  3.79  3.61  3.62  221,184 
10/02/2024 3.75  3.79  3.62  3.74  410,829 
10/01/2024 3.89  3.89  3.69  3.70  340,661 
09/30/2024 3.85  3.98  3.79  3.89  413,194 
09/27/2024 3.97  3.98  3.85  3.87  396,028 
09/26/2024 3.88  3.94  3.80  3.89  337,909 
09/25/2024 3.89  3.94  3.78  3.81  243,488 
09/24/2024 3.97  3.99  3.88  3.90  179,180 
09/23/2024 4.13  4.20  3.94  3.96  357,831 
09/20/2024 4.29  4.29  4.04  4.10  794,251 
09/19/2024 4.21  4.41  4.12  4.35  432,221 
09/18/2024 4.07  4.25  3.99  4.06  277,370 
09/17/2024 4.16  4.24  4.01  4.10  321,929 
09/16/2024 4.08  4.26  3.99  4.12  331,297 
09/13/2024 4.00  4.15  3.99  4.03  239,011 
09/12/2024 3.94  4.07  3.82  4.00  252,296 
09/11/2024 3.94  3.98  3.80  3.91  291,202 
09/10/2024 3.98  3.99  3.76  3.96  371,012 
09/09/2024 3.82  3.86  3.72  3.83  352,096 
09/06/2024 3.96  3.97  3.73  3.79  317,938 
09/05/2024 3.92  4.13  3.87  3.96  181,145 

About MaxCyte Stock history

MaxCyte investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for MaxCyte is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in MaxCyte will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing MaxCyte stock prices may prove useful in developing a viable investing in MaxCyte
Last ReportedProjected for Next Year
Common Stock Shares Outstanding103.3 M66.8 M
Net Loss-21.2 M-22.3 M

MaxCyte Quarterly Net Working Capital

163.37 Million

MaxCyte Stock Technical Analysis

MaxCyte technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of MaxCyte technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of MaxCyte trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Portfolio Suggestion Now

   

Portfolio Suggestion

Get suggestions outside of your existing asset allocation including your own model portfolios
All  Next Launch Module

MaxCyte Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for MaxCyte's price direction in advance. Along with the technical and fundamental analysis of MaxCyte Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of MaxCyte to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for MaxCyte Stock Analysis

When running MaxCyte's price analysis, check to measure MaxCyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MaxCyte is operating at the current time. Most of MaxCyte's value examination focuses on studying past and present price action to predict the probability of MaxCyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MaxCyte's price. Additionally, you may evaluate how the addition of MaxCyte to your portfolios can decrease your overall portfolio volatility.